Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
The introduction of an injectable GLP-1 has opened up new possibilities for patients with type 2 diabetes and obesity
GLP1 Treatments No long-term contracts Personalized plans On-demand medical support Free expedited shipping *Price includes medication only, if prescribed
a systematic review
Digital twin systems integrate physiological data with computational models to optimize patch application, dose adjustments, and drug absorption
These associations were independent of factors including ethnicity, deprivation, microvascular complications, comorbidities, HbA1c, body mass index, and the use of other medications [23]